Fresenius Medical Care (FMS) Tops Q3 EPS by 35c

Fresenius Medical Care (NYSE: FMS) reported Q3 EPS of EUR0.73, EUR0.35 better than the analyst estimate of EUR0.38. Revenue for the quarter came in at EUR4.76 billion versus the consensus estimate of EUR5.4 billion.

For earnings history and earnings-related data on Fresenius Medical Care (FMS) click here.

You May Also Be Interested In

• Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
• Holcim to acquire Fermacell from James Hardie for EUR 840M
• Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance